medical oncology

Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors
Graziela Zibetti Dal Molin, Shannon Neville Westin, Pavlos Msaouel, Larissa M Gomes, Andrea Dickens, Robert L Coleman

International Journal of Gynecologic Cancer Jan 2020, 30 (1) 89-93; DOI: 10.1136/ijgc-2019-000714
Management of recurrent ovarian cancer: when platinum-based regimens are not a therapeutic option
Alice Bergamini, Luca Bocciolone, Andrei Fodor, Massimo Candiani, Giorgia Mangili

International Journal of Gynecologic Cancer Nov 2019, 29 (9) 1431-1436; DOI: 10.1136/ijgc-2019-000624
Treatment patterns and associated factors in patients with advanced epithelial ovarian cancer: a population-based study
Myrte Zijlstra, Maite Timmermans, Heidi Fransen, Maaike van der Aa, An Reyners, Natasja Raijmakers, Lonneke van de Poll-Franse

International Journal of Gynecologic Cancer Jul 2019, 29 (6) 1032-1037; DOI: 10.1136/ijgc-2019-000489
Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: expanding indications and novel combination strategies
Emily Hinchcliff, Shannon Neville Westin, Graziela Dal Molin, Christopher J LaFargue, Robert L. Coleman

International Journal of Gynecologic Cancer Jun 2019, 29 (5) 956-968; DOI: 10.1136/ijgc-2019-000499

Main menu